Company profile
UK company 10076821, incorporated on 22 March 2016.
Evox Therapeutics - Transformative Exosome Therapeutics
EVOX Therapeutics Limited is a UK company with status active founded in 2016 based in South East England.
Company number 10076821
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
SH01 | Transaction MzU0NTY5MTAwMWFkaXF6a2N4
Published 18 Sep 2026 15:22
Company registered at Companies House
Exosome therapeutic technology company
Evox Therapeutics uses vesicles, small bodies made of cellular membranes, to encase drugs and treat a range of severe diseases.
Development of therapeutic exosome technology. Investment from Oxford Sciences Innovation
1 Feb 2019 to 31 Mar 2021
Argininosuccinate lyase (ASL) deficiency is the second most common urea cycle defect. In the most severe form of the disease, symptoms present early in the new-born period progressing to coma and consequent death if untreated. Later presentation can present with aspecific neuro-disability. Patients are managed by pharmacological and dietary intervention, ...
